RBC Capital Downgrades Focus Finl Partners to Sector Perform, Announces $53 Price Target
RBC Capital analyst Daniel Perlin downgrades Focus Finl Partners (NASDAQ:FOCS) from Outperform to Sector Perform and announces $53 price target.
William Blair Downgrades Actinium Pharmaceuticals to Market Perform
William Blair analyst Andy Hsieh downgrades Actinium Pharmaceuticals (AMEX:ATNM) from Outperform to Market Perform.
Raymond James Downgrades First Merchants to Outperform, Announces $50 Price Target
Raymond James analyst Daniel Tamayo downgrades First Merchants (NASDAQ:FRME) from Strong Buy to Outperform and announces $50 price target.
Wells Fargo Downgrades Cable One to Underweight, Lowers Price Target to $680
Wells Fargo analyst Steven Cahall downgrades Cable One (NYSE:CABO) from Equal-Weight to Underweight and lowers the price target from $850 to $680.
JP Morgan Downgrades Sonic Automotive to Neutral, Lowers Price Target to $55
JP Morgan downgrades Sonic Automotive (NYSE:SAH) from Overweight to Neutral and lowers the price target from $60 to $55.
JP Morgan Downgrades AutoNation to Underweight, Raises Price Target to $130
JP Morgan analyst Rajat Gupta downgrades AutoNation (NYSE:AN) from Neutral to Underweight and raises the price target from $125 to $130.
HSBC Downgrades Mosaic to Reduce, Lowers Price Target to $43
HSBC analyst Santhosh Seshadri downgrades Mosaic (NYSE:MOS) from Hold to Reduce and lowers the price target from $45 to $43.
HSBC Downgrades CF Industries Holdings to Hold, Lowers Price Target to $90
HSBC analyst Santhosh Seshadri downgrades CF Industries Holdings (NYSE:CF) from Buy to Hold and lowers the price target from $104 to $90.
JMP Securities Downgrades Claros Mortgage Trust to Market Perform
JMP Securities analyst Steven Delaney downgrades Claros Mortgage Trust (NYSE:CMTG) from Market Outperform to Market Perform.
Analyst Says M&A Could Be A Negative Catalyst For This Aesthetic Company
Needham has downgraded InMode Ltd (NASDAQ:INMD) from Buy to Hold with no price target. The analyst writes that the 1Q23 aesthetics patient…